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Abstract
The neurological damage after cardiac arrest (CA) constitutes a big challenge of hospital discharge.
The therapeutic hypothermia (34 ◦C − 32 ◦C) has shown its benefit to reduce cerebral oxygen demand
and improve neurological outcomes after the cardiac arrest. However, it can have many adverse effects,
among them the cardiac arrhythmia generation represents an important part (up to 34%, according
different clinical studies). Monolayer cardiac culture is prepared with cardiomyocytes from new-born rat
directly on the multi-electrodes array, which allows acquiring the extracellular potential of the culture.
The temperature range is 37 ◦C − 30 ◦C − 37 ◦C, representing the cooling and rewarming process in
the therapeutic hypothermia. Experiments showed that at 35 ◦C, the acquired signals are characterized
by period-doubling phenomenon, compared to signals at other temperatures. Spiral waves, commonly
considered as a sign of cardiac arrhythmia, are observed in the reconstructed activation map. With an
approach from nonlinear dynamics, phase space reconstruction, it is shown that at 35 ◦C, the trajectories
of these signals formed a spatial bifurcation, even trifurcation. Another transit point is found between
30 ◦C − 33 ◦C, which agreed with other clinical studies that induced hypothermia after cardiac arrest
should not be below 32 ◦C.
The process of therapeutic hypothermia after cardiac arrest can be represented by a Pitchfork bifur-
cation type process, which could explain the different ratio of arrhythmia among the adverse effects after
this therapy. This nonlinear dynamics suggests that a variable speed of cooling / rewarming, especially
when passing 35 ◦C, would help to decrease the ratio of post-hypothermia arrhythmia and then improve
the hospital output.
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1 Introduction
The cardiovascular diseases are the leading cause of death in the world. The research in this field has
drawn so much attention of physicians, engineers and researchers since years. However, the cardiovascular
diseases progress overtakes the development of the related treatments : in 2030, the annual number of
deaths due to cardiovascular diseases will be 25 million, according to the World Health Statistics (2012)
by World Health Organization. The majority of patients survived Out-of-Hospital Cardiac Arrest usually
develop some degree of neurological problems, caused by ischemia-reperfusion cerebral injury [1]. Even
though many clinical trials with specific drugs have been conducted against neurological damages after
cardiac arrest, there are no remarkable successes reported. The therapeutic hypothermia seemed as the
only therapy available which can improve the neurological recovery of the patients.
The general temperature for human being is maintained within the range of 36.1 ◦C and 37.8 ◦C [2].
The lower temperature (hypothermia) can be abnormal. However if administered in a controlled way,
it could be therapeutic. In fact, the moderate hypothermia (28 ◦C to 31 ◦C) has been used successfully
during some open-heart surgeries since years. It is just until recently that it began to be used in post-
resuscitation care. The main benefit here is that the therapeutic hypothermia helps to reduce cerebral
oxygen demand and to improve neurological outcomes after the cardiac arrest [3, 4, 5, 6]. When cardiac
arrest happens, the heart ceases abruptly and unexpectedly to function, so the normal blood flux is
considerably disturbed. The heart is no longer able to pump enough blood to the rest of the body.
Without immediate treatment, the brain death can occur in six minutes. After a successful resuscitation,
the brain could still suffer from some reperfusion injury. The induced hypothermia is almost the only
therapy that could reduce the risk of brain damage. The unconscious patient with spontaneous circulation
is cooled to 32 ◦C to 34 ◦C for 12 to 24 hours after the cardiac arrest.
In fact, the use of therapeutic hypothermia following cardiac arrest was reported in the late 1950s
[7, 8]. The results showed some benefits but uncertain. It was also clinically difficult to control the
interval between arrest and cooling which is very important. Therefore, hypothermia for cardiac arrest
has waned for years. Over the past few years, the therapeutic hypothermia began to redraw attentions
of researchers, clinicians etc.. In 2003, The American Heart Association (AHA) endorsed the use of
therapeutic hypothermia following cardiac arrest. The International Liaison Committee on Resuscitation
(ILCOR) recommended also its use [5]. Currently, the hypothermia therapy (HT) was most recommended
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for out-of-hospital cardiac arrest due to ventricular fibrillation [9]. But according to ILCOR, there was
possibility for cardiac arrest from other causes, but the benefit is not always confirmed. For example,
the studies showed that hypothermia did not improve the outcome in non-ventricular-fibrillation cardiac
arrest [10, 11].
The exact mechanism of therapeutic hypothermia is unclear and still under studies. It can be globally
summarized as following : in case of resuscitation after cardiac arrest, reperfusion can continue for up to
24 hours, which could cause significant inflammation in the brain. The induced hypothermia can decrease
intra-cranial pressure, reduce cerebral metabolic rate (even to 40%−50% [12]) and the demand for oxygen
consumption of the brain as well [13, 14, 9]. It helps possibly to suppress many of the chemical reactions
associated with reperfusion injury, including free radical production, excitatory amino acid release, and
calcium shifts, which can in turn lead to mitochondrial damage and apoptosis [15]. In addition, it can
decrease cardiac output by 7% for each 1 ◦C decrease in core body temperature with a stable stroke
volume and the mean arterial pressure [16].
Despite the fact that induced hypothermia after cardiac arrest has been shown to increase the rate of
neurologically intact survival, it can have many adverse effects. The whole treatment must be adequately
monitored, particularly the controlled cooling. The adverse events of hypothermia therapy include pneu-
monia, metabolic and electrolyte disorders, sepsis and bleeding, which are often reported. There is one
another adverse event : the cardiac arrhythmia, which is under discussion. Some investigators state
that there is no significant cardiac arrhythmia after HT [4, 17]. However, other studies did show that
cardiac arrhythmia occurs after HT. According to studies, the cardiac arrhythmia represents 6% ([18])
to 7% − 14% [19], even reaches or 33% − 36% [20, 21] of the total adverse events. So it is important to
understand how the post-hypothermia-arrhythmia raises.
Here comes the motivation of this paper, with an experimental model in vitro : to study the arrhythmia
generation by hypothermia in order to explore its triggering mechanism.
2 Materials and Methods
2.1 Cardiac cells culture
The experimental model used here is primary cardiomyocytes (CM) culture prepared from cardiomyocytes
of new-born rats. One of the major advantages of the CM culture is, that myocardial contractions
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of isolated muscle cells do not affect the stability of intracellular and extracellular electrodes, so the
extracellular potential can be easily recorded by electro / optical sensors. Since there is no surrounding
tissue to the culture, hemodynamic and neurohumoral influences are also absent, the functional and
biochemical responses of cells depend only on cells themselves. Furthermore, isolated CM can be used
under carefully controlled experimental conditions and be reproducible as well. Compared to other rat
heart models, the engineered model in this study featured a mean period of action potential 0.50− 0.72
second in normal conditions. The culture beating (83 − 120 bpm) is similar to normal human heart,
which is different from other similar models (normal rat heart beats at 600 bpm).
The acquired extracellular potential (EP) shares very similar electrophysiological properties of cardiac
muscular cell in situ [22]. This model has been a good tool to study related cardiovascular problems, for
instance, experiments on arrhythmogenic drugs, ischemia, hypoxia etc. [23, 24, 25, 26, 27].
Figure 1. (a) Schematic illustration of the correlation between the extracellular potential and the
action potential. Upper signal : extracellular potential; lower signal : action potential. (b)
Cardiomyocytes culture under microscopy, zoom 40X. The black spots are electrodes of MEA, the
light-yellow transparent objects are the nucleus of the CM.
EP signals have a close correlation of the depolarization and repolarizing phase of the action po-
tentials (Figure 1a). This relationship allows to interpreting indirectly the results at “action potential
propagation” level [28, 29]. Therefore, the CM cultures have the potential to reproduce in vitro a wide
range of pathological conditions such as ischemia reperfusion, the radical stress or thermal shock, and
any combination of these conditions.
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Ethics Statement
This facility has ongoing approval to perform extraction of rat cardiomyocytes; protocols are approved
by the French government, No. 00775, and are in accordance with the US National Institutes of Health
guide for the Care and Use of Laboratory Animals. All animal handling and procedures are performed
by individuals who are appropriate trained, and licensed by the government of France.
2.2 Multi-electrodes Array recording
The extracellular potential of the CM culture is acquired with the multi-electrode array (MEA) system.
The MEA technology allows synchronously recording the extracellular potential. In addition, when
applied to the cardiac cultures, it can provide a better spatial resolution than the mapping procedure by
fluorescence and is less invasive than the conventional electrophysiology methods (intracellular recording
or by patch-clamp) [30, 31].
The MEA, has typically 60 electrodes, aligned in a matrix form 8×8 with an inter-electrodes distance
of 100µm (the four corners are for fixation, so in total 60 electrodes). The electrodes have a diameter
of 30µm. The working region of a typical MEA is about 2.5mm2. Every acquisition consists of 60 EP
signals with a sampling frequency of maximum 50 kHz per channel and a 12 bits resolution. As for the
whole MEA platform, it comprises four parts (more details in [32]: (A) pre-amplification module (PAM) of
extracellular potential signal. (B) Faraday cage where the PAM is placed, in order to reduce environmental
(mainly, electromagnetic) noise. (C) temperature controller, allowing to control the temperature of the
CM culture. Temperature range is 20 ◦C−50 ◦C, temperature response is less than 30 s to 5 min according
to different system. To reduce medium evaporation and dehydration induced by heating of the MEA plate,
the MEA is covered by a Petri dish. (D) signal acquisition / processing system, developed under LabView
and MATLAB.
The Figure 1b shows a CM culture on the MEA under optical microscopy, with 40X zoom. The black
spots are electrodes of MEA, the light-yellow transparent objects are the nucleus of the CM. The cells
form an inter-connected mono-layer cardiac tissue. Since the contraction of cells is synchronized, the
tissue itself contracts automatically.
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3 Results
The therapeutic hypothermia after cardiac arrest consists in two general processes : cooling and rewarm-
ing of patient. We have simulated these two procedures in vitro. For an in vitro model with mono-layer
cardiac cell culture, its cooling and rewarming are much faster than the equivalent procedures in vivo.
The obtained results are similar for both cases, but the “cooling” procedure showed more significant
changes. The details will be discussed lately. After every change of temperature, to ensure that the
culture is well stabilized, it is kept for 8 minutes before the recording. Since the tissue is monolayer
culture, the reach of steady-state is quick. Generally, the signals become stable after 2 or 3 minutes.
Figure 2. Examples acquired signals (matrix 8× 8. No electrode at the 4 corners which are for
fixation). Each panel shows an acquisition from an electrode, the position corresponds to its real
position on the MEA. Signals in blue are good ones, others are excluded.
As shown in Figure 2, the acquired signals (each sub-panel) are presented in a matrix form 8 × 8,
according to the positions of corresponding electrode on the MEA. Not all signals meet the quality
requirements, only selected signals are used (in blue). The others signals are then eliminated. In normal
condition, the culture activates spontaneously, beating regularly and showing stable behavior of regular
period.
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3.1 Single signal : period-doubling
Decreasing the temperature of the culture, the periods of EP signals increase in general (Figure 3). The
periods variation at each temperature could be the consequence of junction-gap remodeling [33]. From
Figure 3. EP signals at different temperatures (cooling from 37 ◦C to 30 ◦C and rewarming back to
37 ◦C).
37 ◦C to 30 ◦C, the period is increased from about 0.5 s to 1.58 s. All periods are regular, except for 35 ◦C,
which showed presence of different period values. In fact, the periods alternate with time in this case.
Taking typical single potential at each temperature (Figure 4a), two main period values are shown at
35 ◦C : the lower value is almost exactly the same as the one at 37 ◦C, higher value is roughly the double.
To better show the evolution of periods, a period diagram for different temperature is presented in Figure
4b. At 35 ◦C, a period-doubling phenomenon is observed. From a point view of nonlinear dynamics, this
period-doubling is a marker when a system is conducted to stat “chaos” [34]. Change temperature down
to 32 ◦C, the periods’ value changed more quickly after this temperature. Entering in 31 ◦C ∼ 30 ◦C, the
periods reach to their maximum values. Since this study focused on mild hypothermia, the experiments
are stopped at 30 ◦C.
According to the recommendation from ILCOR, the hypothermia therapy should at first pass 35 ◦C.
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Figure 4. (a) Comparison of typical single period EP signals. (b) Periods digram, periods-doubling at
T = 35 ◦C. Black points are periods values, red ones are median vales of periods at corresponding
temperature.
The patient’s temperature should above the threshold 32 ◦C, otherwise below which there is a risk of
rebound hyperthermia, dysrhythmias and infections [35]. The result here showed that the 35 ◦C is a
troubling temperature point. A transit point could exist around 32 ◦C. These results agreed with the
clinical recommendation.
3.2 2D activation map : plane waves vs. spiral waves
The basic characteristics of EP signal, period, has been presented. It analyzes the signal from every
electrode. However in the tissue, the action potentials are propagated from on cell (fiber) to anther (cell
/ fiber). As a result, it would be interesting to know how these signals act globally, in a two-dimensional
space. One of the most used tools in this case, is the activation map : a map reconstructed spatially in
function of arriving time of signal. Since in this study, a 8× 8 MEA is used, the reconstructed map here
is then 8 × 8 pixels. Though the image resolution is low (8 × 8 pixels), the main activities in the tissue
can be captured. It is better shown in the real-time video, so please refer to the supplemented videos.
When temperature is different from 35 ◦C, plane waves propagation is observed (supplementary data
: movie plane wave sup01.mp4, movie plane wave sup02.mp4). In Figure 5, nine snapshots have been
presented to show the propagation of plane waves. Their trajectories fluctuate slightly (see the white
arrows in Figure 5), the global propagation is stable and regular, which confirmed that the CM cultures
have highly synchronized electrical activities like those reported for conventional endocellular recordings
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Figure 5. Activation map in normal condition T = 37 ◦C. Plane wave propagation, from time (a) to
(i). White arrows indicate the propagation direction of plane wave.
[36]. However, at 35 ◦C, the activation map is marked by the presence of spiral waves (supplementary
data : movie spiral wave sup01.mp4, movie spiral wave sup02.mp4, movie spiral wave sup03.mp4).
Relevance of spiral waves to the arrhythmogenicity
The spiral waves are commonly considered as a sign of cardiac arrhythmia [37, 38]. In the pioneer
work by [39], they validated experimentally (in vivo) Moe’s hypothesis [40] of multiple wavelet (spiral
waves / micro-reentry) of atrial fibrillation. They showed that there is a critical number of micro-
reentries below which the cardiac arrhythmia can self-terminate. A large number of studies based on this
“defibrillation concept” and its extension “sub-threshold stimulation” have been conducted [41, 42, 43].
These defibrillation methods could provide better termination of fibrillation with less harm to patient,
which is a hot research point in recent years.
For the model in this study, the observation of spiral waves has been reported in previous studies
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with different provocation methods. Arrhythmias could be induced by anomalous conduction, erratic
pacemaker driving [44, 45] or by electrical stimulation [46]. Otherwise, in regular regime, a dominant
pacemaker spontaneously activates the tissue (propagation of plane waves of action potential). The
generation of spiral waves in this model induced by hypothermia, corresponds to clinical studies shown
that in case of cardiac arrest, the therapeutic hypothermia could provoke arrhythmia cardiac [18, 19, 20,
21].
Therefore, the arrhythmogenicity of here-used model has been confirmed.
3.3 Bifurcation from phase space reconstruction
As previously shown, signals at hypothermia 35 ◦C have featured the period-doubling phenomena as well
as spiral waves generation. A closer look at these phenomena reveals further insight on their behavior.
Biological systems depend on many parameters. Under most dynamical regimes, conventional linear
methods predict their behaviors only from one-dimensional time series. In this case, methods from chaos
theory and nonlinear dynamics are therefore suitable to study the unpredictable behaviors of physiological
signals. Among them, the method of phase space reconstruction [47] is a valuable tool for the studies
of this kind of dynamical systems. The principle of this method is to transform the properties of a
time series into topological properties of a geometrical object which is embedded in a space, wherein
all possible states of the system are represented, each state corresponds to a unique point. So that the
reconstructed space sharing the same topological properties as the original one. These states points form
then a set of typical trajectories of the system, which allows showing information such as the existence
of an attractor or limit cycles etc.
Mathematically, under the approach phase space reconstruction, the system can be represented as :
~X(τ,m) = [x(t), x(t+ τ), . . . , x(t+ τ(m− 1))], t = 0, 1, 2, . . . (1)
where ~X denotes the system states and is a function of τ and m, x(t) is the time series, m is the embedding
dimension and τ is the time lag. m is estimated by the method False Nearest Neighbor (FNN) [48], which
intends to find the minimal embedding dimension. As for time lag τ , a method based on autocorrelation
function is used to find optimal values (largest one so that the resulting coordinates for m are relatively
independent) [49].
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In this study, since the signals are regular whatever the temperature is, the difference of their τ is
quite small. The determining parameter is the embedding dimension m. As shown in Figure 6, during the
cooling process, the mean embedding dimension initially decreases when temperature drops from 37 ◦C to
35 ◦C. It increases then slowly up to 3.52 at 31 ◦C to another transition point. The m increases abruptly
after 31 ◦C. When rewarming, the temperature returns to 37 ◦C and m recovers its original value. This
Figure 6. Mean value of embedding dimension m vs. temperature.
reinforces the evidence that a temperature around 35 ◦C contains a transition point for the system. In
case of arrhythmia (spiral waves generation), the embedding dimension decreases, just like other studies
(heart rate variability [50], electroencephalogram [51] etc.) reported that in case of pathology the related
nonlinear parameters are often decreased. The stated transition point 31 ◦C for m re-confirmed the
conclusion found in Figure 6 that in the range of 30 ◦C and 33 ◦C, there exists also a critical temperature.
Typical reconstructed phase spaces at different temperature are presented in Figure 7 and Figure 8.
The trajectories in phase space have all been well-formed. Apart from 35 ◦C, though the original signals
are different, the global forms of their trajectories are similar with just a little variation. This can be
explained by the embedding dimension m = 3.5± 0.3 : despite the fact that there is a variation ±0.3 of
m, it is still relatively small compared to it median value m = 3.5 in the range of 37 ◦C − 30 ◦C. The
widths of the trajectories are relatively tight, which proves from another point of view that the system
is stable. Interesting trajectories are found at T = 35 ◦C, for most signals, the trajectories formed a
bifurcation as in Figure 7, which reflect the period-doubling phenomena (Figure 4b) at T = 35 ◦C.
Rare trifurcation of trajectories (Figure 8) is also captured at this temperature. This bifurcation /
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Figure 7. Phase space reconstruction for EP signals, bifurcation at T = 35 ◦C (time lagging unit:
samples; darker color means looser points density, brighter color denotes higher points density).
trifurcation can be interpreted as supercritical pitchfork bifurcation (Figure 9), with the central path
as a metastable state [52]. The bold black line denotes the stable states of the system. In the dashed
line, the system is in an unstable dynamic state, but it could sustainedly remain there if quasi-static
perturbations are not strong enough to make it fall to the (dynamical) lower energy states. This makes
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Figure 8. Phase space reconstruction for EP signals, trifurcation at T = 35 ◦C (time lagging unit:
samples; darker color means looser points density, brighter color denotes higher points density).
that state a metastable state. From T = 35 ◦C, the system enters the unstable region. For example, if
the system follows the black trajectory (double-line), it will cross twice stability line, which makes the
period-doubling and so bifurcation in phase space will occur. If the system follows the red trajectory
(triple-line), it will cross the stability line three times and exhibit trifurcation. Since in this region the
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Figure 9. Illustration of Bifurcation or Trifurcation (type Pitchfork) of hypothermia effect on EP. The
bold black line denotes stable state of the system. For bold dashed line, the system could show “stable”
(line parts) or “unstable” (empty space) dynamics. Following the black trajectory (double-line), the
system passes twice “stable” state, which makes the bifurcation in their phase space happen. if the
system follows the red trajectory (triple-line), the system would pass three times “stable” state. There
will be a trifurcation for the trajectories in phase space.
transition between stable and unstable states is fast and in most cases it is the unstable states which
dominate the system dynamics, the metastable line is not always observed in practice.
4 Conclusion
The therapeutic hypothermia is considered as a safe and effective therapy after cardiac arrest. It is
recommended for unconscious adult patients with spontaneous circulation after out-of-hospital ventricular
fibrillation cardiac arrest. The outcome is positive.
In this article, the hypothermia effect of extracellular potential with a cardiac model in vitro has been
studied. The object is to study the arrhythmia generation after therapeutic hypothermia to improve
neurological outcome of cardiac arrest. The results showed that at T = 35 ◦C, spiral waves (arrhythmia)
are observed. These spiral waves would disappear when the tissue’s temperature returned to 37 ◦C.
However, in realistic situation, once the arrhythmia happens, it will self-maintain and develop. This will
provoke the global arrhythmia. From a point of view of nonlinear dynamics, it seemed that the process of
hypothermia on cardiac tissue followed a pitchfork bifurcation. According to this diagram (Figure 9), the
arrhythmia generation depends on the “stable” state that the system crossed in this “unstable” region.
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Consequently, it is not certain that staying at 35 ◦C would create surely arrhythmia. This corresponds to
the ratio diversity of arrhythmia among the adverse effects after hypothermia (from 6% up to 33%−36%).
Another finding is that there exists a transit temperature in the range of 33 ◦C−30 ◦C, which is in accord
with the clinical trials that in therapeutic hypothermia the temperature should not be bellow 32 ◦C.
Cooling the tissue with mild hypothermia (≥ 30 ◦C) can induce spiral waves in the tissue. If the tissue
is cooled < 35 ◦C, the spiral waves are auto terminated and transformed into regular plane waves. This
agreed with another study of mild hypothermia effect on termination of spiral waves [53]. And at lower
temperature (deeper hypothermia 5.9 ◦C ± 1.3 ◦C), local cooling facilitates termination of spiral waves
[54]. The latter two studies [54, 53] showed the positive effect of hypothermia in macro / organ scale.
Our study provided instead another evidence at micro / cellular level. In another recent study of the
ECG changes of out-of-hospital cardiac arrest during and after mild therapeutic hypothermia [55], they
reported similar results as ours : the RR-interval is almost doubled during hypothermia (1019± 332 ms)
compared to normal ECG (660±161 ms). This study proved the relevance of our study, at a macro-scale.
So our results would also be applicable to human data.
5 Discussion
In all our experiments, the cooling procedure induced arrhythmia more easily than the rewarming proce-
dure. The potential mechanism would be that when cooling down the tissue, the action potential became
longer and propagated slower. This would disturb the precedent plane waves and made them transform
to spiral waves. However, in the reverse case (rewarming), the new generated waves propagates faster
so that the precedent waves are swept away. In consequence, there is few chance that the current plane
waves could be transformed into spiral waves.
The observed change of dynamics at 35 ◦C looked like the alternans change from 1:1 to 3:2 in case
of Atrio-Ventricular Block (type Wenckebach [56]). Following the Atrio-Ventricular Block explanations,
this could be interpreted as a propagation block which provoked the spiral waves in the tissue at 35 ◦C.
Here, there is one important difference between the studies with paced models and this one. We used
here primary cardiomyocytes tissues which are self-excitable and have spontaneous and regular electrical
/ mechanical activities. If under external electrical stimulation (like the pacing of perfused ventricular
preparations in optical mapping study), the culture’s electrical activities will be disturbed and the normal
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plane wave propagation would be transformed into spiral waves. The propagation block and the period-
doubling could be related one to the other. It is difficult to experimentally justify this point, since the
intrinsic factors are unknown. This would be a limitation of this study. What’s more, the experimental
model differences could be also an obstacle to draw common conclusion.
A possibility of the 1:1→3:2 transition is in case where the cells are not well spatially-coupled, i.e.
important heterogeneity preventing the waves from propagating when the cells are not coupled. For
example, if the third wave is blocked, the 1:1→3:2 transition would thus happen. In this study, the
prepared cells are characterized by their ability to proliferate after dissociation and inoculation. This
helps to obtain a homogeneous monolayer in vitro of cardiac muscle cells population. One should notice,
however, that the homogeneity of the tissue implies that secondary pacemakers can appear anywhere. If
the dominant pacemaker region does not fire at some point (e.g., a 3:2 block) then a secondary pacemaker
that is only slightly longer than the dominant one would drive during the blocked third wave. The resulting
behavior would be complex, by interaction of these two regions, and far from a clear period doubling like
the one observed. Our observations suggest hence a collective behavior, not a local one. The influence of
heterogeneity can be nevertheless a potential way of 1:1→3:2 transition which needs further studies.
Other study showed indeed that 35 ◦C could be a troubling temperature. Chudin et al. [57] reported
that rapid pacing of rabbit ventricular myocytes at 35 ◦C can lead to increased intracellular Ca2+ levels
and then provoke complex action potential pattern, including the alternans change from 1:1 to 3:2. This
provides another supporting evidence of the current result.
A recent work [58] on the role of temperature on nonlinear cardiac dynamics (alternans in paced
ventricular tissues) showed very interesting results. They found that in case of hypothermia (26 ◦C),
“. . . the sigmoidal shape of the restitution curves . . . gives rise to a rejoining of the bifurcation diagram
during progressive reduction of the circuit length . . .”. In our study, we observed similar bifurcation
(temperature-period) at cellular level compared to their study at ventricular level. Even though there is
no straightforward way to compare two different dynamics (auto-excitable vs. pacing; restitution curve
vs. temperature-periods curve), the similarity in both studies implies indeed that there would exist a
hypothermia threshold triggering this potential bifurcation mechanism. More work is needed to determine
hypothermia threshold.
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6 Limitations
One of the main concerns about in vitro studies with rat model is the “difference among species”. While
a rat heart largely differs from a human heart, it is one of the most used animal models to study human
cardiovascular diseases. E.g., it has been successfully used to validate drug targets and to determine
efficacious and safe dosage schemes for combination treatments in humans. The experimental models
do not aim to fully model a disease or disease mechanisms at system level, but rather set out to obtain
specific functional information.
Should be mentioned once again, our experimental model is different from other rat models. It has
similar characteristics as human data, as previously discussed. The objective of the presented manuscript
is to use this model to explore the potential mechanisms of PHA. Nothing in these mechanisms looks
a priori specific to the rat, neither the hypothermal nor the arrhythmic ones. Size and anatomy are
not relevant as we are considering a cultivated tissue. We could of course expect significant quantitative
differences in parameters between rat and human myocytes : The reported bifurcation in the dynamics
could possibly take place at a slightly different temperature. This requires a further extended study,
which is one of the objectives in an on-going project.
The diagram (Figure 9) proposes that the longer that the culture is staying at 35 ◦C, the higher the
probability of arrhythmia would be. It implies also that a variable speed of cooling / rewarming would
help to reduce the possibilities of arrhythmia. However, due to the fact that cooling and rewarming of the
mono-layer cardiac culture is almost instantly, it is not possible to study the effect of speed of cooling /
rewarming with the current culture. To better understand the mechanism, other studies with a full model
(isolated heart or heart in situ) are required. Further experiments and developments are in progress.
Acknowledgments
The authors acknowledge the Institute of Cardiovascular Research (Dijon, Burgundy, France) and the
NVH Medicinal (Dr. David VANDROUX, Dijon, France) for our collaboration in the experimental
data acquisition. The authors acknowledge also the Conseil Re´gional de Bourgogne (Burgundy regional
council) for financial support of this project.
The authors thanks sincerely the unknown reviewers for their constructive and insightful comments.
A
C
C
E
P
T
E
D
18
References
1. J. J. de Vreede-Swagemakers, A. P. Gorgels, W. I. Dubois-Arbouw, J. W. van Ree, M. J. Daemen,
L. G. Houben, and H. J. Wellens, “Out-of-hospital cardiac arrest in the 1990s: A population-based
study in the maastricht area on incidence, characteristics and survival,” Journal of the American
College of Cardiology, vol. 30, pp. 1500–1505, Nov. 1997. (page 2).
2. D. Longo, A. Fauci, D. Kasper, S. Hauser, J. Jameson, and J. Loscalzo, Harrison’s Principles of
Internal Medicine. McGraw-Hill Education, 18th ed., 2011. (page 2).
3. Y. Yanagawa, S. Ishihara, H. Norio, M. Takino, M. Kawakami, A. Takasu, K. Okamoto, N. Kaneko,
C. Terai, and Y. Okada, “Preliminary clinical outcome study of mild resuscitative hypothermia
after out-of-hospital cardiopulmonary arrest,” Resuscitation, vol. 39, pp. 61–66, Nov. 1998. (page
2).
4. S. A. Bernard, T. W. Gray, M. D. Buist, B. M. Jones, W. Silvester, G. Gutteridge, and K. Smith,
“Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia,”
New England Journal of Medicine, vol. 346, no. 8, pp. 557–563, 2002. (pages 2, 3).
5. W. Group, J. Nolan, P. Morley, and al., “Therapeutic hypothermia after cardiac arrest: An advi-
sory statement by the advanced life support task force of the international liaison committee on
resuscitation,” Circulation, vol. 108, no. 1, pp. 118–121, 2003. (page 2).
6. E. M. Moore, A. D. Nichol, S. A. Bernard, and R. Bellomo, “Therapeutic hypothermia: Benefits,
mechanisms and potential clinical applications in neurological, cardiac and kidney injury,” Injury,
vol. 42, pp. 843–854, Sept. 2011. (page 2).
7. G. R. Williams and F. C. Spencer, “The clinical use of hypothermia following cardiac arrest,”
Annals of Surgery, vol. 148, no. 3, pp. 462–466, 1958. (page 2).
8. D. W. Benson, G. R. Williams, F. C. Spencer, and A. J. Yates, “The use of hypothermia after
cardiac arrest,” Anesthesia & Analgesia, vol. 38, no. 6, pp. 423–428, 1959. (page 2).
9. J. Knot and Z. Mot’ovska´, “Therapeutic hypothermia after cardiac arrest–part 2 evidence from
randomized, observational trials,” Cor et Vasa, vol. 54, pp. e243–e247, July 2012. (page 3).
A
C
C
E
P
T
E
D
19
10. C. W. Don, W. Longstreth, Jr, C. Maynard, M. Olsufka, G. Nichol, T. Ray, N. Kupchik, S. Deem,
M. K. Copass, L. A. Cobb, and F. Kim, “Active surface cooling protocol to induce mild therapeutic
hypothermia after out-of-hospital cardiac arrest: a retrospective before-and-after comparison in a
single hospital.,” Crit Care Med, vol. 37, pp. 3062–3069, Dec 2009. (page 3).
11. F. Dumas, D. Grimaldi, B. Zuber, and et al., “Is hypothermia after cardiac arrest effective in
both shockable and nonshockable patients? insights from a large registry,” Circulation, vol. 123,
pp. 877–886, Mar 2011. (page 3).
12. D. W. Busija and C. W. Leﬄer, “Hypothermia reduces cerebral metabolic rate and cerebral blood
flow in newborn pigs,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 253,
no. 4, pp. H869–H873, 1987. (page 3).
13. M. Holzer and W. Behringer, “Therapeutic hypothermia after cardiac arrest and myocardial infarc-
tion,” Best Practice & Research Clinical Anaesthesiology, vol. 22, pp. 711–728, Dec. 2008. (page
3).
14. J. Knot and Z. Mot’ovska´, “Therapeutic hypothermia after cardiac arrest–part 1: Mechanism of
action, techniques of cooling, and adverse events,” Cor et Vasa, vol. 54, pp. e237–e242, July 2012.
(page 3).
15. P. Calver, T. Braungardt, N. Kupchik, A. Jensen, and C. Cutler, “The big chill: improving the
odds after cardiac arrest.,” RN, vol. 68, pp. 58–62; quiz 63, May 2005. (page 3).
16. J. Varon, “Therapeutic hypothermia: implications for acute care practitioners.,” Postgrad Med,
vol. 122, pp. 19–27, Jan 2010. (page 3).
17. M. Tiainen, H. J. Parikka, M. A. Ma¨kija¨rvi, O. S. Takkunen, S. J. Sarna, and R. O. Roine,
“Arrhythmias and heart rate variability during and after therapeutic hypothermia for cardiac
arrest,” Critical Care Medicine, vol. 37, no. 2, pp. 403–409, 2009. (page 3).
18. J. Arrich and T. E. R. C. H. A. C. A. R. S. Group, “Clinical application of mild therapeutic
hypothermia after cardiac arrest,” Critical Care Medicine, vol. 35, no. 4, pp. 1041–1047, 2007.
(pages 3, 10).
A
C
C
E
P
T
E
D
20
19. N. I. Nikolaou, A. H. Christou, E. C. Papadakis, A. I. Marinakos, and S. P. Patsilinakos, “Mild
therapeutic hypothermia in out-of-hospital cardiac arrest survivors.,” Hellenic J Cardiol, vol. 53,
no. 5, pp. 380–389, 2012. (pages 3, 10).
20. N. Nielsen, J. Hovdenes, F. Nilsson, S. Rubertsson, and et al., “Outcome, timing and adverse
events in therapeutic hypothermia after out-of-hospital cardiac arrest,” Acta Anaesthesiologica
Scandinavica, vol. 53, no. 7, pp. 926–934, 2009. (pages 3, 10).
21. HACA, “Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest,”
New England Journal of Medicine, vol. 346, no. 8, pp. 549–556, 2002. PMID: 11856793. (pages 3,
10).
22. T. Watanabe, L. M. Delbridge, J. O. Bustamante, and T. F. McDonald, “Heterogeneity of the
action potential in isolated rat ventricular myocytes and tissue.,” Circulation Research, vol. 52,
no. 3, pp. 280–90, 1983. (page 4).
23. A. Grynberg, E. Fantini, P. Athias, M. Degois, L. Guenot, M. Courtois, and S. Khatami, “Modi-
fication of the n-6/n-3 fatty acid ratio in the phospholipids of rat ventricular myocytes in culture
by the use of synthetic media: functional and biochemical consequences in normoxic and hypoxic
conditions,” Journal of molecular and cellular cardiology, vol. 20, no. 10, pp. 863–874, 1988. (page
4).
24. A. Chevalier, L. Demaison, A. Grynberg, and P. Athias, “Influence of phospholipid polyunsatured
fatty acid composition on some metabolic disorders induced in rat cardiomyocytes by hypoxia and
reoxygenation,” Journal of molecular and cellular cardiology, vol. 22, no. 10, pp. 1177–1186, 1990.
(page 4).
25. E. Fantini, L. Demaison, E. Sentex, A. Grynberg, and P. Athias, “Some biochemical aspects of
the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation,”
Journal of molecular and cellular cardiology, vol. 26, no. 8, pp. 949–958, 1994. (page 4).
26. I. Durot, P. Athias, F. Oudot, and A. Grynberg, “Influence of phospholipid long chain polyunsatu-
rated fatty acid composition on neonatal rat cardiomyocyte function in physiological conditions and
during glucose-free hypoxia-reoxygenation,” Molecular and cellular biochemistry, vol. 175, no. 1-2,
pp. 253–262, 1997. (page 4).
A
C
C
E
P
T
E
D
21
27. P. Delerive, F. Oudot, B. Ponsard, S. Talpin, J. P. Sergiel, C. Cordelet, P. Athias, and A. Grynberg,
“Hypoxia-reoxygenation and polyunsaturated fatty acids modulate adrenergic functions in cultured
cardiomyocytes,” Journal of molecular and cellular cardiology, vol. 31, no. 2, pp. 377–386, 1999.
(page 4).
28. A. Fendyur and M. E. Spira, “Towards on-chip, in-cell recordings from cultured cardiomyocytes
by arrays of gold mushroom-shaped microelectrodes,” Frontiers in Neuroengineering, vol. 5, pp. –,
2012. (page 4).
29. M. Reppel, F. Pillekamp, Z. J. Lu, M. Halbach, K. Brockmeier, B. K. Fleischmann, and J. Hes-
cheler, “Microelectrode arrays: A new tool to measure embryonic heart activity,” Journal of Elec-
trocardiology, vol. 37, Supplement, pp. 104–109, Oct. 2004. (page 4).
30. K. Banach, M. D. Halbach, P. Hu, J. Hescheler, and U. Egert, “Development of electrical activity
in cardiac myocyte aggregates derived from mouse embryonic stem cells,” American Journal of
Physiology - Heart and Circulatory Physiology, vol. 284, no. 6, pp. H2114–H2123, 2003. (page 5).
31. F. Pillekamp, M. Reppel, K. Brockmeier, and J. Hescheler, “Impulse propagation in late-stage
embryonic and neonatal murine ventricular slices,” Journal of Electrocardiology, vol. 39, pp. 425.e1–
425.e4, oct 2006. (page 5).
32. S. Jacquir, S. Binczak, B. Xu, G. Laurent, D. Vandroux, P. Athias, and J. Bilbault, “Investigation
of micro spiral waves at cellular level using a microelectrode array technology,” Int. J. Bifurcation
Chaos, vol. 21, pp. 1–15, 2011. (page 5).
33. S. Rohr, “Role of gap junctions in the propagation of the cardiac action potential,” Cardiovascular
Research, vol. 62, no. 2, pp. 309–322, 2004. (page 7).
34. Q. Ho-Kim, N. Kumar, N. Kumar, and H. Lam, Invitation to Contemporary Physics. World
Scientific, 2004. (page 7).
35. P. J. Safar and P. M. Kochanek, “Therapeutic hypothermia after cardiac arrest,” N Engl J Med,
vol. 346, pp. 612–613, Feb. 2002. (page 8).
A
C
C
E
P
T
E
D
22
36. C. Tissier, S. Bes, D. Vandroux, E. Fantini, L. Rochette, and P. Athias, “Specific electromechan-
ical responses of cardiomyocytes to individual and combined components of ischemia,” Canadian
Journal of Physiology and Pharmacology, vol. 80, no. 12, pp. 1145–1157, 2002. (page 9).
37. J. M. Davidenko, A. V. Pertsov, R. Salomonsz, W. Baxter, and J. Jalife, “Stationary and drifting
spiral waves of excitation in isolated cardiac,” Nature, vol. 355, pp. 349–351, jan 1992. (page 9).
38. A. Winfree, “Electrical turbulence in three-dimensional heart muscle,” Science, vol. 266, pp. 1003–
1006, nov 1994. (page 9).
39. M. Allessie, W. Lammers, F. Bonke, and J. Hollen, “Experimental evaluation of moe’s multiple
wavelet hypothesis of atrial fibrillation,” Cardiac Electrophysiology and Arrhythmias. New York:
Grune & Stratton, pp. 265–276, 1985. (page 9).
40. G. K. Moe, W. C. Rheinboldt, and J. A. Abildskov, “On the multiple wavelet hypothesis of atrial
fibrillation,” Arch Inr Pharmarcodyn Ther, vol. 140, pp. 183–188, 1962. (page 9).
41. A. T. Stamp, G. V. Osipov, and J. J. Collins, “Suppressing arrhythmias in cardiac models using
overdrive pacing and calcium channel blockers,” Chaos, vol. 12, pp. 931–940, sep 2002. (page 9).
42. A. V. Panfilov, S. C. Mu¨ller, V. S. Zykov, and J. P. Keener, “Elimination of spiral waves in cardiac
tissue by multiple electrical shocks,” Phys. Rev. E, vol. 61, pp. 4644–4647, apr 2000. (page 9).
43. B. Xu, S. Jacquir, G. Laurent, J.-M. Bilbault, and S. Binczak, “A hybrid stimulation strategy for
suppression of spiral waves in cardiac tissue,” Chaos, Solitons & Fractals, vol. 44, pp. 633–639, aug
2011. (page 9).
44. P. Athias, J. Moalic, C. Frelin, J. Klepping, and P. Padieu, “Rest and active potentials of dissociated
rat heart cells in culture,” Comptes rendus des se´ances de la Socie´te´ de biologie et de ses filiales,
vol. 171, no. 1, p. 86, 1977. (page 10).
45. P. Athias, C. Frelin, B. Groz, J. Dumas, J. Klepping, and P. Padieu, “Myocardial electrophysiology:
intracellular studies on heart cell cultures from newborn rats.,” Pathologie-biologie, vol. 27, no. 1,
p. 13, 1979. (page 10).
A
C
C
E
P
T
E
D
23
46. P. Athias, S. Jacquir, C. Tissier, D. Vandroux, S. Binczak, J. Bilbault, and M. Rosse´, “Exci-
tation spread in cardiac myocyte cultures using paired microelectrode and microelectrode array
recordings,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 6, p. S3, 2007. (page 10).
47. F. Takens, “Detecting strange attractors in turbulence,” in Dynamical Systems and Turbulence,
Lecture Notes in Mathematics (D. Rand and L.-S. Young, eds.), vol. 898, pp. 366–381, Springer
Berlin / Heidelberg, 1981. (page 10).
48. M. B. Kennel, R. Brown, and H. D. I. Abarbanel, “Determining embedding dimension for phase-
space reconstruction using a geometrical construction,” Phys. Rev. A, vol. 45, pp. 3403–3411, mar
1992. (page 10).
49. A. M. Albano, J. Muench, C. Schwartz, A. I. Mees, and P. E. Rapp, “Singular-value decomposition
and the grassberger-procaccia algorithm,” Phys. Rev. A, vol. 38, pp. 3017–3026, sep 1988. (page
10).
50. J.-F. Casties, D. Mottet, and D. Le Gallais, “Non-linear analyses of heart rate variability during
heavy exercise and recovery in cyclists.,” Int J Sports Med, vol. 27, pp. 780–785, Oct 2006. (page
11).
51. A. Celletti and A. Villa, Low-dimensional chaotic attractors in the rat brain, vol. 74, pp. 387–393.
Springer-Verlag, 1996. (page 11).
52. S. Rasband, Chaotic dynamics of nonlinear systems. A Wiley-Interscience publication, Wiley, 1990.
(page 12).
53. M. Harada, H. Honjo, M. Yamazaki, H. Nakagawa, Y. S. Ishiguro, Y. Okuno, T. Ashihara,
I. Sakuma, K. Kamiya, and I. Kodama, “Moderate hypothermia increases the chance of spiral
wave collision in favor of self-termination of ventricular tachycardia/fibrillation,” American Jour-
nal of Physiology - Heart and Circulatory Physiology, vol. 294, no. 4, pp. H1896–H1905, 2008.
(page 15).
54. M. Yamazaki, H. Honjo, T. Ashihara, M. Harada, I. Sakuma, K. Nakazawa, N. Trayanova, M. Horie,
J. Kalifa, J. Jalife, K. Kamiya, and I. Kodama, “Regional cooling facilitates termination of spiral-
A
C
C
E
P
T
E
D
24
wave reentry through unpinning of rotors in rabbit hearts,” Heart Rhythm, vol. 9, pp. 107–114,
Jan. 2012. (page 15).
55. M. Rauber, D. Stajer, M. Noc, T. T. Schlegel, and V. Starc, “High resolution ecg changes in
survivors of out-of-hospital cardiac arrest during and after mild therapeutic hypothermia,” in
Computing in Cardiology, 2013. (page 15).
56. M. Talajic, D. Papadatos, C. Villemaire, L. Glass, and S. Nattel, “A unified model of atrioventric-
ular nodal conduction predicts dynamic changes in wenckebach periodicity.,” Circulation Research,
vol. 68, no. 5, pp. 1280–93, 1991. (page 15).
57. E. Chudin, J. Goldhaber, A. Garfinkel, J. Weiss, and B. Kogan, “Intracellular ca2+ dynamics and
the stability of ventricular tachycardia,” Biophysical journal, vol. 77, no. 6, pp. 2930–2941, 1999.
(page 16).
58. F. H. Fenton, A. Gizzi, C. Cherubini, N. Pomella, and S. Filippi, “Role of temperature on nonlinear
cardiac dynamics.,” Phys Rev E Stat Nonlin Soft Matter Phys, vol. 87, p. 042717, Apr 2013. (page
16).
